Infective endocarditis in a Finnish teaching hospital: a study on 326 episodes treated during 1980-2004

M Heiro1, H Helenius, S Mäkilä

  • 1Department of Medicine, Turku University Hospital, Finland. maija.heiro@tyks.fi

Abstract

Insights

Infective endocarditis (IE) patterns shifted over 25 years, driven by increased intravenous drug use (IVDU). While patient age rose, outcomes for non-IVDU patients remained stable, with changes in causative agents and affected valves.

Area of Science:

  • Cardiology
  • Infectious Diseases
  • Epidemiology

Background:

  • Infective endocarditis (IE) is a serious infection affecting heart valves.
  • Understanding temporal trends in IE is crucial for adapting clinical management and public health strategies.

Purpose of the Study:

  • To analyze changes in the clinical characteristics, causative agents, affected valves, and outcomes of infective endocarditis (IE) over a 25-year period.

Main Methods:

  • A retrospective evaluation of 326 IE episodes in 303 patients treated between 1980 and 2004.
  • Analysis of clinical data, including patient demographics, causative pathogens, valve involvement, predisposing conditions, complications, and treatment outcomes.

Main Results:

  • The mean patient age increased significantly. A notable rise in IE associated with intravenous drug use (IVDU) was observed after 1996.
  • Staphylococcus aureus became the predominant pathogen, replacing Viridans streptococci. Mitral and tricuspid valve involvement increased, while aortic valve IE decreased, largely due to IVDU.
  • The incidence of lung emboli rose significantly, primarily in IVDU patients. However, neurological complications, heart failure, surgical treatment rates, and mortality remained unchanged.

Conclusions:

  • Significant shifts in IE epidemiology occurred over 25 years, primarily linked to an increase in IVDU-associated cases.
  • Changes in causative agents and valve predilection were observed, with a rise in Staphylococcus aureus and increased involvement of mitral and tricuspid valves.
  • Despite evolving clinical features, the overall outcomes and mortality for infective endocarditis remained stable, with non-addicted patient presentations largely unchanged.

Related Concept Videos

Endocarditis I: Introduction01:25

Endocarditis I: Introduction

Introduction:Endocarditis is the infection of the endocardium, the inner lining of the heart and its valves. When the heart muscle is involved, the condition is termed myocarditis, while an infection of the outer lining is called pericarditis. Infective endocarditis (IE) primarily affects the endocardium, where pathogens adhere to the valves or lining, forming vegetation that can lead to severe complications. Infective endocarditis occurs when microorganisms, usually bacteria from other body...
Endocarditis IV: Nursing Management01:29

Endocarditis IV: Nursing Management

Infective endocarditis (IE) is a chronic infection of the heart's endocardium, primarily affecting the heart valves. A detailed nursing assessment for a patient with IE involves collecting subjective and objective data to ensure an accurate diagnosis and timely intervention.Subjective DataThe nurse gathers information about the patient's symptoms and complaints during the subjective assessment. Patients with infective endocarditis often report non-specific symptoms that can mimic other...
Endocarditis III: Medical Management01:18

Endocarditis III: Medical Management

Infective endocarditis management involves a multifaceted approach encompassing infection prevention, lifestyle modifications, pharmacological therapy, and surgical management.Infection Prevention:Hand Hygiene: Thorough handwashing is crucial to prevent the spread of infection. Hand hygiene should be performed regularly, especially before and after using the restroom.Oral Hygiene: Good oral hygiene is essential. It includes brushing teeth immediately after waking up and before bed, flossing...
Endocarditis II: Clinical Features of Infective Endocarditis01:25

Endocarditis II: Clinical Features of Infective Endocarditis

Endocarditis can present various clinical features depending on the causative organism and the patient's underlying health conditions. Initially, the clinical features of infective endocarditis develop gradually, presenting with nonspecific symptoms that can be easily mistaken for other illnesses.General SymptomsEarly symptoms of infective endocarditis are fever, chills, weakness, malaise, fatigue, and weight loss. These symptoms reflect the systemic nature of the infection and the body's...
Myocarditis III: Medical Management01:14

Myocarditis III: Medical Management

Myocarditis: Comprehensive Medical ManagementMyocarditis, the heart muscle inflammation, requires a comprehensive medical management strategy that addresses the underlying cause, provides supportive care, manages symptoms, and reduces cardiac workload.Infections and Autoimmune CausesAdminister appropriate antimicrobial therapy when an infectious agent causes myocarditis. For instance, penicillin treats infections caused by Group A Streptococcus. In cases where autoimmune processes are...
Healthcare Associated Infections I: Iatrogenic, Exogenic and Endogenic01:26

Healthcare Associated Infections I: Iatrogenic, Exogenic and Endogenic

Healthcare-associated infections (HAIs) occur in a healthcare facility while a person receives care for another ailment. This category also includes work-related infections among healthcare staff.
HAIs significantly increase the cost of health care. Extended stays in healthcare institutions, increased disability, increased costs of medications, including specialized antibiotics, and prolonged recovery times add to the patient's expenses and the healthcare institution and funding bodies. Common...